Concepedia
Statistics
Publications
7
Citations
269
H-Index
Active since
2011
Affiliations
Neovii Biotech (Germany)(Current)
University Medical Center Hamburg-Eppendorf
Universität Hamburg
Forschungsinstitut für Mineralische und Metallische Werkstoffe Edelsteine/Edemetalle
Diane Seimetz is an author at Neovii Biotech (Germany) specializing in drug repurposing, translational medicine, and drug discovery.
Top concepts
MedicineCell TherapyPharmacologyTherapeuticsDrug DiscoveryPharmacotherapyDrug DevelopmentDrug RepurposingDrug RepositioningRegenerative Medicine
Publications per year
2011–2018
Novel Monoclonal Antibodies for Cancer Treatment: The Trifunctional Antibody Catumaxomab (Removab<sup>®</sup>)
Diane Seimetz · Journal of Cancer · 2011 · 89 citations · Full text
Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites
Marion Ott, Frederik Marmé, Gerhard Moldenhauer et al. · International Journal of Cancer · 2011 · 76 citations · Full text
Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation
Annegret Vaggelas, Diane Seimetz · Therapeutic Innovation & Regulatory Science · 2018 · 36 citations
Regenerative Medicine, Preclinical Therapeutics, Translational Medicine +12
The trifunctional antibody catumaxomab amplifies and shapes tumor-specific immunity when applied to gastric cancer patients in the adjuvant setting
Djordje Atanackovic, Henrike Reinhard, Sabrina Meyer et al. · Human Vaccines & Immunotherapeutics · 2013 · 23 citations · Full text
The Role of Relative Lymphocyte Count as a Biomarker for the Effect of Catumaxomab on Survival in Malignant Ascites Patients: Results from a Phase II/III Study
M. M. Heiss, Michael A. Ströhlein, Carsten Bokemeyer et al. · Clinical Cancer Research · 2014 · 21 citations
1–5 of 7